Hosted on MSN1mon
Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant Depression
The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.
pharmaphorum1d
J&J’s Spravato for depression ‘should be much cheaper’
Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression (TRD) too high to offer value for money, says a US cost-effectiveness body. The Institute for Clinical ...
Medical News Today12d
Spravato interactions: Alcohol, medications, and other factors
If Spravato doesn’t come with paperwork, you can ask your doctor or pharmacist to print a copy. If you need help reading or understanding this information, ask your doctor or pharmacist.
Wane1mon
Viking Psychiatry: Spravato Approved as a Monotherapy
Living Local 15 host Jessica Williams is joined by Sean Goddard, a Psychiatric Nurse Practitioner and Owner of Viking Psychiatry, to speak about the recent approval for Spravato as a monotherapy ...